Journals / Turkish Journal of Urology / 2021 / Cilt: 47 - Sayı: 4

Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome

Pages
325–337
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients with glomerulations might be good candidates for early com- bined intravesical therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To define the relationship between cystoscopic findings, including novel findings such as the hypervascularization, of bladder pain syndrome/interstitial cystitis (BPS/IC) and the response to intravesical therapy.
📊
Key Findings & Data:All patients received early intravesical combined therapy (ICT), ie, within 2 hours after hydrodistention.
💡
Conclusion & Impact:Patients with glomerulations might be good candidates for early com- bined intravesical therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: To define the relationship between cystoscopic findings, including novel findings such as the hypervascularization, of bladder pain syndrome/interstitial cystitis (BPS/IC) and the response to intravesical therapy. Material and methods: We retrospectively evaluated cystoscopy findings in patients who had a preliminary diagnosis of BPS/IC. All patients received early intravesical combined therapy (ICT), ie, within 2 hours after hydrodistention. Additionally, ICT was continued according to our protocol. Cystoscopic findings were classi- fied as glomerulations, hypervascularization, and Hunner’s lesion (HL). The therapy responses were evaluated at 1st, 3rd, 6th, and 12th months using the visual analog scale (VAS), O’Leary/Sant interstitial cystitis symp- tom index (ICSI), and interstitial cystitis problem index (ICPI) scores. Results: Out of 61 patients, HL was diagnosed during cystoscopy in six (9.8%) patients, glomerulations in 35 (57.4%) patients, and hypervascularization in 15 (24.6%) patients. No pathological findings were defined in five (8.2%) patients. In the glomerulation and hypervascularization group, the median VAS, ICSI, and ICPI scores were lower than those in the preoperative period in the follow-up. In patients with HL, the median VAS scores were lower in the entire follow-up compared to the preoperative period, with an increase at 1st year compared to 6th month, and ICSI scores were lower than preoperative period in the entire follow-up, with an increase at 3rd month and 1st year. ICPI scores were also lower during the follow-up, with an increase observed in the 1st year. Conclusion: The presence of hypervascularization should be defined since it might show different characteris- tics that may affect the ICT response. Patients with glomerulations might be good candidates for early com- bined intravesical therapy.

🔖

Cite This Article

EROL, B., KAZAN, H. O., KESER, F., EFİLOGLU, O., DANACIOĞLU, Y. O., ONUR, R. (2021). Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome. Turkish Journal of Urology, Cilt: 47 - Sayı: 4, 325–337. https://ajindex.com/articles/404235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Doggweiler R, Whitmore KE, Meijlink JM, et al. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society. Neurourol Urodynam. 2017
  2. 36(4):984-1008. [CrossRef] 2. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syn- drome/interstitial cystitis: An ESSIC proposal. Eur Urol. 2008
  3. 53(1):60-67. [CrossRef] 3. Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015
  4. 193(5):1545-1553. [Cross- Ref] 4. Peeker R, Fall M. Toward a precise definition of interstitial cysti- tis: Further evidence of differences in classic and nonulcer dis- ease. J Urol. 2002
  5. 167(6):2470-2472. [CrossRef] 5. Doiron RC, Tolls V, Irvine-Bird K, Kelly KL, Nickel JC. Clinical phenotyping does not differentiate Hunner lesion subtype of inter- stitial cystitis/bladder pain syndrome: A relook at the role of cys- toscopy. J Urol. 2016
  6. 196(4):1136-1140. [CrossRef] 6. Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodis- tention? Neurourol Urodyn. 2005
  7. 24(7):638-642. [CrossRef] 7. Cheng C, Rosamilia A, Healey M. Diagnosis of interstitial cysti- tis/bladder pain syndrome in women with chronic pelvic pain: A prospective observational study. Int Urogynecol J. 2012
  8. 23(10):1361-1366. [CrossRef] 8. O’Leary MP, Sant GR, Fowler FJ, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997
  9. 49(5):58-63. [CrossRef] 9. Kiuchi H, Tsujimura A, Takao T, et al. Increased vascular endo- thelial growth factor expression in patients with bladder pain syn- drome/interstitial cystitis: Its association with pain severity and glomerulations. BJU Int. 2009
  10. 104(6):826-831. [CrossRef] 10. Peng CH, Jhang JF, Shie JH, Kuo HC. Down regulation of vascu- lar endothelial growth factor is associated with decreased inflam- mation after intravesical onabotulinumtoxina injections combined with hydrodistention for patients with interstitial cystitis—Clini- cal results and immunohistochemis. Urology. 2013
  11. 82(6):1452.e1-1452.e6. [CrossRef] 11. Furuta A, Suzuki Y, Igarashi T, et al. Angiogenesis in bladder tis- sues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome. Int J Urol. 2019